The hidden continuum of HIV-associated cardiomyopathy: A focussed review with case reports

Pieter-Paul S Robbertse1, Anton F Doubell1, Jean B Nachega2,3,4

  • 1Division of Cardiology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Academic Hospital, Tygerberg, South Africa.

SA Heart Journal
|May 9, 2022
PubMed

Insights

HIV-associated cardiomyopathy (HIVAC) presents with asymptomatic myocardial abnormalities, even at HIV diagnosis. Understanding these early signs is crucial for prognosis and managing heart conditions in people with HIV.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Medical Imaging

Background:

  • HIV-associated cardiomyopathy (HIVAC) is poorly understood with a grim prognosis post-ventricular dysfunction.
  • Asymptomatic myocardial abnormalities are prevalent in people living with HIV, detected via cardiovascular magnetic resonance.
  • These abnormalities, including ventricular thickening and inflammation, may indicate early stages of HIVAC.

Purpose of the Study:

  • To explore the significance of asymptomatic myocardial pathology in HIV.
  • To understand early disease on a continuum towards advanced cardiomyopathy.
  • To highlight the need for prospective research in treatment-naïve individuals.

Main Methods:

  • Utilized cardiovascular magnetic resonance (CMR) to assess myocardial abnormalities.
  • Analyzed prevalence and characteristics of asymptomatic cardiac pathology in people with HIV.
  • Compared findings with symptomatic HIVAC cases.

Main Results:

  • Revealed a significant burden of asymptomatic myocardial abnormalities in people living with HIV.
  • Identified abnormalities present even at the time of HIV diagnosis.
  • Observed thickened, inflamed ventricles resembling symptomatic HIVAC.

Conclusions:

  • Asymptomatic HIV-associated myocardial pathology represents an early stage of potential cardiomyopathy.
  • Further prospective research in anti-retroviral therapy-naïve individuals is essential.
  • Improved understanding of early cardiac changes is key to managing HIVAC.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...